COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 1777: Articles 17761-17770  | Next

Before the Surge: Molecular Evidence of SARS-CoV-2 in New York City Prior to the First Report
Hernandez, M. M., Gonzalez-Reiche, A. S., Alshammary, H., Fabre, S., Khan, Z., van De Guchte, A., Obla, A., Ellis, E., Sullivan, M. J., Tan, J., Alburquerque, B., Soto, J., Wang, C.-Y., Sridhar, S. H., Wang, Y.-C., Smith, M., Sebra, R., Paniz-Mondolfi, A. E., Gitman, M. R., Nowak, M. D., Cordon-Cardo, C., Luksza, M., Krammer, F., van Bakel, H., Simon, V., Sordillo, E. M.
10.1101/2021.02.08.21251303 — Posted: 2021-02-11
A SARS-CoV-2 lineage A variant (A.23.1) with altered spike has emerged and is dominating the current Uganda epidemic
Lule Bugembe, D., Phan, M. V. T., Ssewanyana, I., Semanda, P., Nansumba, H., Dhaala, B., Nabadda, S., O'Toole, A., Rambaut, A., Kaleebu, P., Cotten, M.
10.1101/2021.02.08.21251393 — Posted: 2021-02-11
Clinical Validation of Automated and Rapid mariPOC SARS-CoV-2 Antigen Test
Koskinen, J. M., Antikainen, P., Hotakainen, K., Haveri, A., Ikonen, N., Savolainen-Kopra, C., Koskinen, J. O.
10.1101/2021.02.08.21250086 — Posted: 2021-02-11
Accelerating COVID-19 research with graph mining and transformer-based learning
Tyagin, I., Kulshrestha, A., Sybrandt, J., Matta, K., Shtutman, M., Safro, I.
10.1101/2021.02.11.430789 — Posted: 2021-02-11
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
S Arunachalam, P., Walls, A. C., Golden, N., Atyeo, C., Fischinger, S., Li, C., Aye, P., Navarro, M. J., Lai, L., Edara, V. V., Roltgen, K., Rogers, K., Shirreff, L., Ferrell, D. E., Wrenn, S., Pettie, D., Kraft, J. C., Miranda, M. C., Kepl, E., Sydeman, C., Brunette, N., Murphy, M., Fiala, B., Carter, L., White, A. G., Trisal, M., Hsieh, C.-L., Russell-Lodrigue, K., Monjure, C., Dufour, J., Doyle-Meyer, L., Bohm, R. B., Maness, N. J., Roy, C., Plante, J. A., Plante, K. S., Zhu, A., Gorman, M. J., Shin, S., Shen, X., Fontenot, J., Gupta, S., O Hagan, D. T., Most, R. V. D., Rappuoli, R., Coffman, R. L., Novack, D., McLellan, J. S., Subramaniam, S., Montefiori, D., Boyd, S. D., Flynn, J. L., Alter, G., Villinger, F., Kleanthous, H., Rappaport, J., Suthar, M., King, N. P., Veesler, D., Pulendran, B.
10.1101/2021.02.10.430696 — Posted: 2021-02-11
Differential roles of RIG-I-like receptors in SARS-CoV-2 infection
Yang, D., Geng, T., Harrison, A. G., WANG, P.
10.1101/2021.02.10.430677 — Posted: 2021-02-11
Bifurcated monocyte states are predictive of mortality in severe COVID-19
Cillo, A. R., Somasundaram, A., Shan, F., Cardello, C., Workman, C. J., Kitsios, G. D., Ruffin, A., Kunning, S., Lampenfeld, C., Onkar, S., Grebinowski, S., Deshmukh, G., Methe, B., Liu, C., Nambulli, S., Andrews, L., Duprex, W. P., Joglekar, A. J., Benos, P. V., Ray, P., Ray, A., McVerry, B. J., Zhang, Y., Lee, J. S., Das, J., Singh, H., Morris, A., Bruno, T. C., Vignali, D. A.
10.1101/2021.02.10.430499 — Posted: 2021-02-10
In vitro evolution of Remdesivir resistance reveals genome plasticity of SARS-CoV-2
Szemiel, A. M., Merits, A., Orton, R. J., MacLean, O., Wickenhagen, A., Lieber, G., Pinto, R. M., Turnbull, M. L., Wang, S., Mair, D., da Silva Filipe, A., Willett, B. J., Wilson, S. J., Patel, A. H., Thomson, E. C., Palmarini, M., Kohl, A., Stewart, M. E.
10.1101/2021.02.01.429199 — Posted: 2021-02-10
SARS-CoV-2 infection models using in vivo and in vitro hACE2-lentivirus transduction
Rawle, D. J., Le, T. T., Dumenil, T., Yan, K., Tang, B., Bishop, C., Suhrbier, A.
10.1101/2021.02.09.430547 — Posted: 2021-02-10
Naive human B cells can neutralize SARS-CoV-2 through recognition of its receptor binding domain
Feldman, J., Bals, J., Denis, K. S., Lam, E. C., Hauser, B. M., Ronsard, L., Sangesland, M., Moreno, T. B., Okonkwo, V., Hartojo, N., Balazs, A. B., Lingwood, D., Schmidt, A. G.
10.1101/2021.02.02.429458 — Posted: 2021-02-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).